As part of the agreement, Olympus Biotech will become exclusive distributor for the BonAlive Biomaterials BonAlive granules product line in Germany, France and the UK.
The product line covers regenerative products for orthopaedic and trauma surgeries.
BonAlive Biomaterials CEO Fredrik Ollila said the firm’s new partnership with Olympus will help in providing a complete portfolio of bone regeneration products to the community of orthopaedic and trauma surgeons.
"The establishment of a complete product offering will generate value and bring new opportunities in treatment of chronically infected bone," Ollila added.
